Canada Pharmaceuticals

HLS Therapeutics Inc (HLS)

Track

Track

HLS Therapeutics Inc. recorded four insider trading transactions over the past ninety days, all representing open market purchases. Three executives acquired shares totaling 17,870.32 USD. These activities occurred following the August 12th earnings report, which showed a 62.5 percent positive surprise, while the stock price remains near its yearly low.
Ticker: HLS Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for HLS Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Lennox, Ryan Christopher Senior Officer of Issuer Officer
Transaction date
Purchase
Price
451.08
Quantity 80,454 -44.3%
Value CA$3,644,993
2.6
Hanna, John Gordon Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
189.13
Quantity 60,861 -37.0%
Value CA$3,132,828
1.3
Millian, Craig Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
262.93
Quantity 17,110 -42.8%
Value US$2,947,898
1.3
Millian, Craig Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
2.79
Quantity 2,000 +13.8%
Value US$5,580
1.3
Millian, Craig Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
3.16
Quantity 2,000 +16.0%
Value US$6,320
2.6
Hanna, John Gordon Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
4.30
Quantity 4,000 +50.0%
Value CA$17,200
2.4
Edinboro, Dawn Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.95
Quantity 100 +16.7%
Value CA$495
2.4
Edinboro, Dawn Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.97
Quantity 600
Value CA$2,982
3.6
Welborn, Jr., John Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
3.93
Quantity 42,184 +42.6%
Value CA$165,783
1.5
Beauchamp, Norma Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
3.91
Quantity 500
Value CA$1,957
3.6
Welborn, Jr., John Lee Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
3.25
Quantity 2,100 +2.2%
Value CA$6,825
1.5
Beauchamp, Norma Director of Issuer Non-Executive Director
Transaction date
Sale
Price
3.31
Quantity 500
Value CA$1,655
2.6
Hanna, John Gordon Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
3.19
Quantity 1,200 +17.6%
Value CA$3,828
2.6
Hanna, John Gordon Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
3.19
Quantity 2,800 +70.0%
Value CA$8,932
1.3
Millian, Craig Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
2.90
Quantity 2,500 +25.0%
Value US$7,250
1.5
Walsh, Brian Thomas Senior Officer of Issuer Officer
Transaction date
Purchase
Price
2.91
Quantity 1,000 +500.0%
Value US$2,910
1.5
Walsh, Brian Thomas Senior Officer of Issuer Officer
Transaction date
Purchase
Price
2.92
Quantity 200
Value US$584
1.4
Polar Asset Management Partners Inc. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
3.70
Quantity 2,400 +0.0%
Value CA$8,877
1.4
Polar Asset Management Partners Inc. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
4.30
Quantity 20,000
Value CA$86,000
1.4
Polar Asset Management Partners Inc. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
4.36
Quantity 10,000 +0.2%
Value CA$43,600
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-08 2026-09-08 B Purchase
Lennox, Ryan Christopher

Senior Officer of Issuer

Officer
80,454 -44.3%
451.08
CA$3,644,993 		80,454 -44.3% 451.08 CA$3,644,993
2026-09-08 2026-09-01 B Purchase
2.6
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
60,861 -37.0%
189.13
CA$3,132,828 		60,861 -37.0% 189.13 CA$3,132,828
2026-08-24 2026-08-20 B Purchase
1.3
Millian, Craig

Director of Issuer, Senior Officer of Issuer

Executive Director
17,110 -42.8%
262.93
US$2,947,898 		17,110 -42.8% 262.93 US$2,947,898
2026-08-18 2026-08-17 B Purchase
1.3
Millian, Craig

Director of Issuer, Senior Officer of Issuer

Executive Director
2,000 +13.8%
2.79
US$5,580 		2,000 +13.8% 2.79 US$5,580
2026-06-17 2026-06-17 B Purchase
1.3
Millian, Craig

Director of Issuer, Senior Officer of Issuer

Executive Director
2,000 +16.0%
3.16
US$6,320 		2,000 +16.0% 3.16 US$6,320
2026-06-17 2026-06-16 B Purchase
2.6
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
4,000 +50.0%
4.30
CA$17,200 		4,000 +50.0% 4.30 CA$17,200
2025-06-19 2025-06-18 B Purchase
2.4
Edinboro, Dawn

Senior Officer of Issuer

Officer
100 +16.7%
4.95
CA$495 		100 +16.7% 4.95 CA$495
2025-06-19 2025-06-18 B Purchase
2.4
Edinboro, Dawn

Senior Officer of Issuer

Officer
600
4.97
CA$2,982 		600 4.97 CA$2,982
2025-01-08 2024-12-31 B Purchase
3.6
Welborn, Jr., John Lee

Director of Issuer

Non-Executive Director
42,184 +42.6%
3.93
CA$165,783 		42,184 +42.6% 3.93 CA$165,783
2024-12-27 2024-12-24 B Purchase
1.5
Beauchamp, Norma

Director of Issuer

Non-Executive Director
500
3.91
CA$1,957 		500 3.91 CA$1,957
2024-12-16 2024-12-12 B Purchase
3.6
Welborn, Jr., John Lee

Director of Issuer

Non-Executive Director
2,100 +2.2%
3.25
CA$6,825 		2,100 +2.2% 3.25 CA$6,825
2024-11-14 2024-11-14 S Sale
1.5
Beauchamp, Norma

Director of Issuer

Non-Executive Director
500
3.31
CA$1,655 		500 3.31 CA$1,655
2024-08-14 2024-08-14 B Purchase
2.6
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
1,200 +17.6%
3.19
CA$3,828 		1,200 +17.6% 3.19 CA$3,828
2024-08-14 2024-08-13 B Purchase
2.6
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
2,800 +70.0%
3.19
CA$8,932 		2,800 +70.0% 3.19 CA$8,932
2024-05-16 2024-05-15 B Purchase
1.3
Millian, Craig

Director of Issuer, Senior Officer of Issuer

Executive Director
2,500 +25.0%
2.90
US$7,250 		2,500 +25.0% 2.90 US$7,250
2023-11-15 2023-11-15 B Purchase
1.5
Walsh, Brian Thomas

Senior Officer of Issuer

Officer
1,000 +500.0%
2.91
US$2,910 		1,000 +500.0% 2.91 US$2,910
2023-11-15 2023-11-13 B Purchase
1.5
Walsh, Brian Thomas

Senior Officer of Issuer

Officer
200
2.92
US$584 		200 2.92 US$584
2023-11-14 2023-11-10 B Purchase
1.4
Polar Asset Management Partners Inc.

10% Security Holder of Issuer

Large shareholder
2,400 +0.0%
3.70
CA$8,877 		2,400 +0.0% 3.70 CA$8,877
2023-11-14 2023-11-10 B Purchase
1.4
Polar Asset Management Partners Inc.

10% Security Holder of Issuer

Large shareholder
20,000
4.30
CA$86,000 		20,000 4.30 CA$86,000
2023-11-14 2023-11-09 B Purchase
1.4
Polar Asset Management Partners Inc.

10% Security Holder of Issuer

Large shareholder
10,000 +0.2%
4.36
CA$43,600 		10,000 +0.2% 4.36 CA$43,600
Explore more

More insider trading research around HLS Therapeutics Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America